5 Best Biotech Stocks Under $10

4. Kezar Life Sciences, Inc. (NASDAQ:KZR)

Number of Hedge Fund Holders: 28

Total Value: $231.68 million

Share Price as of August 30: $9.84

Based in California, the biotech firm Kezar Life Sciences, Inc. (NASDAQ:KZR) develops therapies for cancer and immunological disorders. The company focuses on using small cell molecules to target diseases. In June, following the release of results from its Phase II clinical trial examining the use of zetomipzomib for the treatment of Lupus Nephritis, Kezar Life Sciences, Inc. (NASDAQ:KZR) shares increased by 92%. 

As of August 2022, the company had a market cap of $672.75 million. Suvretta Capital Management is the largest shareholder in Kezar Life Sciences, Inc. (NASDAQ:KZR). For the second quarter, the company reported earnings per share of -$0.25, beating estimates by $0.03. 

According to Insider Monkey’s Q2 data, 28 hedge funds had stakes in Kezar Life Sciences, Inc. (NASDAQ:KZR). The total value of the holdings is $231.68 million.